{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:14:55Z","timestamp":1763968495672,"version":"build-2065373602"},"reference-count":20,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T00:00:00Z","timestamp":1665878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Psychosocial health is a key driver of quality of life (QoL) in axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA), but it is often overlooked in clinical practice. We aimed to analyze this aspect of QoL by using the Assessment of SpA International Society\u2013Health Index (ASAS HI) in both SpA phenotypes. Patients and methods: One hundred and eleven patients with axSpA and 90 with PsA were consecutively recruited from two rheumatology centers. In both populations, the categories of stress handling (ASAS HI items #11 and 17) and emotional functions (ASAS HI item #13) were analyzed based on the International Classification of Functioning, Disability, and Health (ICF). A multivariate regression model was used to analyze the explanatory factors associated with positive responses to these items. Results: Thirty-four of the 90 PsA patients (37.8%) and 37\/111 of the patients (33.3%) with axSpA reported a positive response to at least one of the stress-handling items. Compared to the patients with PsA, patients with axSpA were less likely to report stress-handling issues (OR 0.48, p &lt; 0.05). Thirty-one of the 90 PsA patients (34.4%) and 44\/111 of the patients (39.6%) with axSpA reported positive responses to item #13. In both groups of SpA patients, disease activity and severity (OR 6.6, p &lt; 0.001) were independently associated with alterations in psychosocial health. Compared with those in the axSpA group, the psychosocial health items were better correlated with each other and with the ASAS HI sum score in the PsA group. Conclusions: Psychosocial health is frequently altered in SpA. Both disease activity and severity are associated with this issue. However, psychosocial factors seem to have a greater impact on QoL in PsA than in axSpA.<\/jats:p>","DOI":"10.3390\/jcm11206094","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T02:29:46Z","timestamp":1665973786000},"page":"6094","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-7145","authenticated-orcid":false,"given":"Rub\u00e9n","family":"Queiro","sequence":"first","affiliation":[{"name":"Rheumatology Division, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain"},{"name":"ISPA Translational Immunology Division, 33011 Oviedo, Spain"},{"name":"School of Medicine, Oviedo University, 33003 Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Alonso","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-909X","authenticated-orcid":false,"given":"Isla","family":"Morante","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Hospital de Sierrallana, 39300 Torrelavega, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Alperi","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2147\/PPA.S162420","article-title":"Patient-reported outcomes in European spondyloarthritis patients: A systematic review of the literature","volume":"12","author":"Queiro","year":"2018","journal-title":"Patient Prefer. Adherence"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12955-020-01422-z","article-title":"Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire","volume":"18","author":"Coates","year":"2020","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11926-019-0819-8","article-title":"The European Map of Axial Spondyloarthritis: Capturing the patient per-spective\u2014An analysis of 2846 patients across 13 countries","volume":"21","author":"Poddubnyy","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.semarthrit.2020.02.001","article-title":"Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis","volume":"50","author":"Zusman","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s40744-021-00321-z","article-title":"Personal Experiences with Diagnostic Delay among Axial Spondyloarthritis Patients: A Qualitative Study","volume":"8","author":"Dube","year":"2021","journal-title":"Rheumatol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40744-021-00297-w","article-title":"Patient Perceptions of Psoriatic Arthritis Management and Communication with Physicians in Australia: Results from a Patient Survey","volume":"8","author":"Lim","year":"2021","journal-title":"Rheumatol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","article-title":"A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: Elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative","volume":"73","author":"Gossec","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/annrheumdis-2013-203967","article-title":"Development of a health index in patients with ankylosing spondylitis (ASAS HI): Final result of a global initiative based on the ICF guided by ASAS","volume":"74","author":"Kiltz","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40744-020-00202-x","article-title":"The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review","volume":"7","author":"Tasende","year":"2020","journal-title":"Rheumatol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/rheumatology\/keab798","article-title":"Differentiating facets of quality of life between spondyloarthritis phenotypes: Added value of the ASAS health index","volume":"61","author":"Queiro","year":"2022","journal-title":"Rheumatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3899\/jrheum.200025","article-title":"Performance of the ASAS health index for the evaluation of spondyloarthritis in daily practice","volume":"47","author":"Pardo","year":"2020","journal-title":"J. Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/rheumatology\/keaa626","article-title":"Construct validity of the ASAS health index in psoriatic arthritis: A cross-sectional analysis","volume":"60","author":"Morante","year":"2021","journal-title":"Rheumatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7525-7-25","article-title":"The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: A comparison with a selected sample of healthy people","volume":"7","author":"Salaffi","year":"2009","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1007\/s00296-011-2190-6","article-title":"Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?","volume":"32","author":"Rajnpreht","year":"2012","journal-title":"Rheumatol. Int."},{"key":"ref_15","first-page":"63","article-title":"Benefit of Biological Drugs for Quality of Life in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Clinical Trials","volume":"1335","author":"Dudek","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11136-019-02308-4","article-title":"No deterioration in health-related quality of life in patients with axial spondyloarthritis followed for 5 years in ordinary outpatient clinics in the biological treatment era","volume":"29","author":"Rohde","year":"2020","journal-title":"Qual. Life Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semarthrit.2017.05.010","article-title":"The psychosocial burden of psoriatic arthritis","volume":"47","author":"Husni","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1759720X20970028","DOI":"10.1177\/1759720X20970028","article-title":"Depression in patients with spondyloarthritis: Prevalence, incidence, risk, factors, mechanisms and management","volume":"12","author":"Parkinson","year":"2020","journal-title":"Ther. Adv. Musculoskelet Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/1744666X.2018.1468252","article-title":"Quality of life in psoriatic arthritis","volume":"14","author":"Gudu","year":"2018","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3899\/jrheum.200586","article-title":"The ASAS Health Index: A New Era for Health Impact Assessment in Spondyloar-thritis","volume":"49","author":"Alonso","year":"2022","journal-title":"J. Rheumatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/20\/6094\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:55:16Z","timestamp":1760144116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/20\/6094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,16]]},"references-count":20,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["jcm11206094"],"URL":"https:\/\/doi.org\/10.3390\/jcm11206094","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2022,10,16]]}}}